Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Bimatoprost may help treat hair loss from alopecia areata.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib may help treat severe hair loss, but more research is needed.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

The document suggests using a topical Vitamin D treatment for hair loss rather than oral supplements and calls for more research.

Low vitamin D levels might indicate more severe hair loss in alopecia areata patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.